Safe and Objective Assay of Enterovirus 71 Neutralizing Antibodies via Pseudovirus

Chemical Research in Chinese Universities ›› 2012, Vol. 28 ›› Issue (1): 91-95.

• Articles • Previous Articles Next Articles

Safe and Objective Assay of Enterovirus 71 Neutralizing Antibodies via Pseudovirus

JIN Jun¹, XU Lin¹, GUO Shi-jie², SUN Shi-yang¹, ZHANG Shu¹, ZHU Chang-lin³, KONG Wei^1*, JIANG Chun-lai^1*

1. National Engineering Laboratory for AIDS Vaccine, College of Life Science, Jilin University, Changchun 130012, P. R. China;
2. Department of Pediatrics, the First Hospital of Jilin University, Changchun 130021, P. R. China;
3. Changchun Baike Biotechnology Co., Changchun 130012, P. R. China

Received:2011-07-13 Revised:2011-10-18 Online:2012-01-25 Published:2011-12-27
Contact: Jun Jin E-mail:weikong@jlu.edu.cn; jiangcl@jlu.edu.cn
Supported by:
Supported by the National Natural Science Foundation of China(No.20872048).

Abstract

Abstract: Current serum neutralization assays based on the inhibition of the cytopathic effect(Nt-CPE) need to manipulate live viruses, which are time-consuming, labor-intensive, and have the potential exposure to infectious agents, so a safe and objective assay via pseudovirus for the fast and efficient detection of enterovirus 71(EV71) neutralizing antibodies was developed. First, we generated EV71 pseudovirus containing firefly luciferase gene in place of the capsid gene P1 in EV71 genome. Vero cells infected with 200 CCID₅₀(50% cell culture infective dose) of EV71 pseudovirus for 24 h were found to have the best performance. Seval sera were measured by EV71 pseudoparticle neutralization assay(Nt-PPN) and the conventional serological method Nt-CPE. Neutralizing antibody titers measured by Nt-PPN and those obtained by Nt-CPE demonstrate a high correlation between the two methods. Overall, the PPN assay represents a valid alternative to conventional serological methods for the evaluation of EV71 neutralizing antibodies. This method can be used for detecting neutralizing antibodies of other picornaviruses, such as hepatitis A virus( HAV) and coxsackievirus 16(CVA16), and make it possible to determine whether there is cross-reactivity between EV71 and CVA16.

Key words: Enterovirus 71(EV71), Pseudovirus, Luciferase, Neutralizing antibody assay

JIN Jun, XU Lin, GUO Shi-jie, SUN Shi-yang, ZHANG Shu, ZHU Chang-lin, KONG Wei, JIANG Chun-lai. Safe and Objective Assay of Enterovirus 71 Neutralizing Antibodies via Pseudovirus[J]. Chemical Research in Chinese Universities, 2012, 28(1): 91-95.

References

[1] Yan J. J., Su I. J., Chen P. F., Liu C. C., Yu C. K., Wang J. R., J.Med. Virol., 2001, 65, 331 [2] Perez-Velez C. M., Anderson M. S., Robinson C. C., McFarland E.J., Nix W. A., Pallansch M. A., Oberste M. S., Glode M. P., Clin.Infect. Dis., 2007, 45, 950 [3] Zhu R. N., Qian Y., Deng J., Xing J. F., Zhao L. Q., Wang F., LiaoB., Ren X. X., Li Y., Zhang Q., Li J., Chinese Journal of Epidemiology,2007, 28, 1004 [4] Chang L. Y., King C. C., Hsu K. H., Ning H. C., Tsao K. C., Li C.C., Huang Y. C., Shih S. R., Chiou S. T., Chen P. Y., Chang H. J.,Lin T. Y., Pediatrics, 2002, 109, e88 [5] Kung S. H., Wang S. F., Huang C. W., Hsu C. C., Liu H. F., Yang J.Y., Clin. Microbiol. Infect., 2007, 13, 782 [6] Huang M. L., Chiang P. S., Luo S. T., Liou G. Y., Lee M. S., J. Virol.Methods, 2010, 165, 42 [7] Arita M., Nagata N., Sata T., Miyamura T., Shimizu H., J. Gen.Virol., 2006, 87, 3317 [8] Li H., Jiang C. L., Yu X. H., Wu Y. G., Li W., Kong W., Chem. J.Chinese Universities, 2008, 29(7), 1384 [9] Arita M., Ami Y., Wakita T., Shimizu H., J. Virol., 2008, 82, 1787 [10] Luo S. T., Chiang P. S., Chao A. S., Liou G. Y., Lin R., Lin T. Y.,Lee M. S., Emerg. Infect. Dis., 2009, 15, 581 [11] Troupin C., Dehee A., Schnuriger A., Vende P., Poncet D.,Garbarg-Chenon A., J. Virol., 2010, 84, 6711 [12] Kobinger G. P., Figueredo J. M., Rowe T., Zhi Y., Gao G.,Sanmiguel J. C., Bell P., Wivel N. A., Zitzow L. A., Flieder D. B.,Hogan R. J., Wilson J. M., Vaccine, 2007, 25, 5220 [13] Temperton N. J., Chan P. K., Simmons G., Zambon M. C., Tedder R.S., Takeuchi Y., Weiss R. A., Emerg. Infect. Dis., 2005, 11, 411 [14] Bartosch B., Bukh J., Meunier J. C., Granier C., Engle R. E.,Blackwelder W. C., Emerson S. U., Cosset F. L., Purcell R. H., Proc.Natl. Acad. Sci. USA, 2003, 100, 14199 [15] Keck Z. Y., Li T. K., Xia J., Bartosch B., Cosset F. L., Dubuisson J.,Foung S. K., J. Virol., 2005, 79, 13199 [16] Netski D. M., Mosbruger T., Depla E., Maertens G., Ray S. C.,Hamilton R. G., Roundtree S., Thomas D. L., McKeating J., Cox A.,Clin. Infect. Dis., 2005, 41, 667 [17] Mascola J. R., Souza P. D., Gilbert P., Hahn B. H., Haigwood N. L.,Morris L., Petropoulos C. J., Polonis V. R., Sarzotti M., MontefioriD. C., J. Virol., 2005, 79, 10103 [18] Wright E., Temperton N. J., Marston D. A., McElhinney L. M.,Fooks A. R., Weiss R. A., J. Gen. Virol., 2008, 89, 2204 [19] Brown B. A., Oberste M. S., Alexander J. P. Jr., Kennett M. L.,Pallansch M. A., J. Virol., 1999, 73, 9969

Safe and Objective Assay of Enterovirus 71 Neutralizing Antibodies via Pseudovirus

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments